Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia
US5120722A · kind A · utility
13Cited by
11References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 1990 |
| Grant date | Jun 9, 1992 |
| Priority date | — |
| Expiry date | Mar 19, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The compounds 1.alpha.,25(S), 26-trihydroxy-.DELTA..sup.22 -cholecalciferol; 1.alpha.,25(R), 26-trihydroxy-.DELTA..sup.22 -cholecalciferol; 1.alpha.,25(S),26-trihydroxyergocalciferol, 1.alpha.,25(R),26-trihydroxyergocalciferol and pharmaceutical compositions comprising the compounds as well as methods of making and using these compounds are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.